4 -

Individualised treatment plans advocated in paediatric asthma

Increases in the incidence of asthma and asthma-related deaths have prompted the Canadian Paediatric Society to attempt to aid physicians in the treatment of paediatric asthma. They consider that all children with asthma should receive an individualised, written treatment plan encouraging self-management. Inhaled corticosteroids (initially with a trial of sodium cromoglycate [cromolyn sodium]) are advocated for children using inhaled beta agonist therapy more than twice-daily. Doses should be as low as possible with beta agonists reserveq for 'breakthrough' wheeze and oral corticosteroid therapy reserved for intermittent, short term use in children with severe asthma. Allergy Section. Canadian Paediatric Society. Treatment of chronic asthma in children: the changing role of inhaled corticosteroids. Canadian Medical Association Journal 145: 637-638. 15 Sep 1991 7'/9'

19 Oct 1991 INPHARMA® ISSN 0156-2703/91/1019-0004/0$01.00/0 © Adis I"ter"atio"al Ltd